company

CHRISTIANIA NEVROLOGIPRAKSIS AS

1459 NESODDEN

Return on Equity
55,17 %
Current Ratio
2,14
Debt-to-Equity Ratio
0,1
Key figures (NOK)2022
Revenue3 675 000
Net Income774 000
Total Assets2 311 000
Total Equity1 403 000
Income (NOK)2022
Revenue3 675 000
Expenditure2 678 000
Operating Profit997 000
Financial Income0
Financial Costs4 000
Financial Balance−4 000
Earnings Before Tax993 000
Tax218 000
Net Income774 000
Balance (NOK)2022
Total Fixed Assets681 000
Total Current Assets1 630 000
Total Assets2 311 000
Total Retained Equity1 373 000
Total Equity1 403 000
Total Long-Term Debt144 000
Total Current Debt763 000
Total Equity and Debt2 311 000
Cash flow (NOK)2022
Sales Income298 000
Other Income3 377 000
Revenue3 675 000
Cost of Goods Sold7 000
Salary Costs1 752 000
Depreciation52 000
Impairment0
Expenditure2 678 000
Operating Profit997 000
Financial Income0
Financial Costs4 000
Financial Balance−4 000
Dividends200 000
Net Income774 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets16 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures50 000
Total Tangible Assets50 000
Total Fiancial Fixed Assets615 000
Total Fixed Assets681 000
Stock0
Total Investments0
Cash, Bank1 467 000
Total Current Assets1 630 000
Total Assets2 311 000
Total Equity1 403 000
Short-Term Group Debt0
Total Long-Term Debt144 000
Creditors26 000
Unpaid Taxes134 000
Dividends200 000
Other Current Debt181 000
Total Current Debt763 000
Total Equity and Debt2 311 000
Financial indicators2022
Return on Equity55,17 %
Debt-to-Equity Ratio0,1
Operating Profit Margin27,13 %
Current Ratio2,14
Quick Ratio2,14
Equity Ratio0,61
Gross Profit Margin99,81 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English